Literature DB >> 33553211

Keep Your Friends Close, but Your Enemies Closer: Role of Acid Sphingomyelinase During Infection and Host Response.

Ha-Yeun Chung1,2, Ralf A Claus3.   

Abstract

Breakdown of the inert and constitutive membrane building block sphingomyelin to the highly active lipid mediator ceramide by extracellularly active acid sphingomyelinase is tightly regulated during stress response and opens the gate for invading pathogens, triggering the immune response, development of remote organ failure, and tissue repair following severe infection. How do one enzyme and one mediator manage all of these affairs? Under physiological conditions, the enzyme is located in the lysosomes and takes part in the noiseless metabolism of sphingolipids, but following stress the protein is secreted into circulation. When secreted, acid sphingomyelinase (ASM) is able to hydrolyze sphingomyelin present at the outer leaflet of membranes to ceramide. Its generation troubles the biophysical context of cellular membranes resulting in functional assembly and reorganization of proteins and receptors, also embedded in highly conserved response mechanisms. As a consequence of cellular signaling, not only induction of cell death but also proliferation, differentiation, and fibrogenesis are affected. Here, we discuss the current state of the art on both the impact and function of the enzyme during host response and damage control. Also, the potential role of lysosomotropic agents as functional inhibitors of this upstream alarming cascade is highlighted.
Copyright © 2021 Chung and Claus.

Entities:  

Keywords:  FIASMA; ceramide (CER); inhibitor; organ failure (OF); sepsis; sphingomyelinase (SMase)

Year:  2021        PMID: 33553211      PMCID: PMC7859284          DOI: 10.3389/fmed.2020.616500

Source DB:  PubMed          Journal:  Front Med (Lausanne)        ISSN: 2296-858X


  178 in total

Review 1.  Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications.

Authors:  Johannes Kornhuber; Philipp Tripal; Martin Reichel; Christiane Mühle; Cosima Rhein; Markus Muehlbacher; Teja W Groemer; Erich Gulbins
Journal:  Cell Physiol Biochem       Date:  2010-05-18

Review 2.  Depression.

Authors:  Gin S Malhi; J John Mann
Journal:  Lancet       Date:  2018-11-02       Impact factor: 79.321

3.  Staphylococcus aureus Alpha-Toxin Disrupts Endothelial-Cell Tight Junctions via Acid Sphingomyelinase and Ceramide.

Authors:  Björn Fahsel; Hannes Kemper; Joelina Mayeres; Katrin Anne Becker; Cao Li; Barbara Wilker; Simone Keitsch; Matthias Soddemann; Carolin Sehl; Marcus Kohnen; Michael J Edwards; Heike Grassmé; Charles C Caldwell; Aaron Seitz; Martin Fraunholz; Erich Gulbins
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

Review 4.  Sphingomyelinases: enzymology and membrane activity.

Authors:  Félix M Goñi; Alicia Alonso
Journal:  FEBS Lett       Date:  2002-10-30       Impact factor: 4.124

5.  Caspase-dependent and -independent activation of acid sphingomyelinase signaling.

Authors:  Jimmy A Rotolo; Jianjun Zhang; Manjula Donepudi; Hyunmi Lee; Zvi Fuks; Richard Kolesnick
Journal:  J Biol Chem       Date:  2005-04-22       Impact factor: 5.157

6.  The urine from patients with peritonitis as a rich source for purifying human acid sphingomyelinase and other lysosomal enzymes.

Authors:  L E Quintern; T S Zenk; K Sandhoff
Journal:  Biochim Biophys Acta       Date:  1989-06-08

7.  Alveolar lipoproteinosis in an acid sphingomyelinase-deficient mouse model of Niemann-Pick disease.

Authors:  Machiko Ikegami; Rajwinder Dhami; Edward H Schuchman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-12-20       Impact factor: 5.464

8.  Regulation of the inflammasome by ceramide in cystic fibrosis lungs.

Authors:  Heike Grassmé; Alexander Carpinteiro; Michael J Edwards; Erich Gulbins; Katrin Anne Becker
Journal:  Cell Physiol Biochem       Date:  2014-06-16

9.  Doxorubicin enhances TRAIL-induced cell death via ceramide-enriched membrane platforms.

Authors:  Claudia Alexandra Dumitru; Alexander Carpinteiro; Tanja Trarbach; Ulrich R Hengge; Erich Gulbins
Journal:  Apoptosis       Date:  2007-08       Impact factor: 4.677

10.  Differential activation of acid sphingomyelinase and ceramide release determines invasiveness of Neisseria meningitidis into brain endothelial cells.

Authors:  Alexander Simonis; Sabrina Hebling; Erich Gulbins; Sibylle Schneider-Schaulies; Alexandra Schubert-Unkmeir
Journal:  PLoS Pathog       Date:  2014-06-12       Impact factor: 6.823

View more
  5 in total

1.  You aren't IMMUNE to the ceramides that accumulate in cardiometabolic disease.

Authors:  Joseph V Varre; William L Holland; Scott A Summers
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2022-02-23       Impact factor: 5.228

2.  Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for Therapeutic Strategies.

Authors:  Murad Abusukhun; Martin S Winkler; Stefan Pöhlmann; Onnen Moerer; Konrad Meissner; Björn Tampe; Heike Hofmann-Winkler; Michael Bauer; Markus H Gräler; Ralf A Claus
Journal:  Front Immunol       Date:  2021-12-20       Impact factor: 7.561

Review 3.  Acid Sphingomyelinase Deficiency: A Clinical and Immunological Perspective.

Authors:  Carolina Pinto; Diana Sousa; Vladimir Ghilas; Andrea Dardis; Maurizio Scarpa; Maria Fatima Macedo
Journal:  Int J Mol Sci       Date:  2021-11-28       Impact factor: 5.923

4.  Difficulty in Repurposing Selective Serotonin Reuptake Inhibitors and Other Antidepressants with Functional Inhibition of Acid Sphingomyelinase in COVID-19 Infection.

Authors:  Pascal Le Corre; Gwenolé Loas
Journal:  Front Pharmacol       Date:  2022-03-03       Impact factor: 5.810

5.  Update on Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) in SARS-CoV-2 Infection.

Authors:  Gwenolé Loas; Pascal Le Corre
Journal:  Pharmaceuticals (Basel)       Date:  2021-07-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.